Published in Proc Natl Acad Sci U S A on July 01, 1993
c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol (1999) 8.17
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J (2001) 4.85
Translational control in cancer. Nat Rev Cancer (2010) 4.59
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell (2007) 4.10
The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res (2001) 4.08
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev (2002) 3.71
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest (2004) 3.70
Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A (2002) 3.55
Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast. Genes Dev (1997) 3.31
Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J (1996) 2.86
Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J (1995) 2.78
Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol (1993) 2.75
Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS One (2007) 2.35
Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis. Nucleic Acids Res (2000) 2.23
An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol Cell Biol (1996) 2.22
Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev (1999) 2.15
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis. Proc Natl Acad Sci U S A (2011) 2.14
Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc Natl Acad Sci U S A (2000) 1.89
HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol Cell Biol (2000) 1.71
The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol (2001) 1.65
Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol Cell Biol (1996) 1.60
Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc Natl Acad Sci U S A (1994) 1.56
An isoform of eIF4E is a component of germ granules and is required for spermatogenesis in C. elegans. Development (2001) 1.53
hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol (2005) 1.50
MYC: connecting selective transcriptional control to global RNA production. Nat Rev Cancer (2015) 1.47
Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J (2000) 1.42
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol (1999) 1.42
What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway. Cancer Discov (2013) 1.38
Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol (1999) 1.38
MYC, Metabolism, and Cancer. Cancer Discov (2015) 1.29
Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia. Blood (2011) 1.27
Antiproliferative Properties of Type I and Type II Interferon. Pharmaceuticals (Basel) (2010) 1.22
A novel function for Myc: inhibition of C/EBP-dependent gene activation. Proc Natl Acad Sci U S A (1996) 1.22
Differential Requirements for eIF4E Dose in Normal Development and Cancer. Cell (2015) 1.20
Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. Br J Cancer (1998) 1.16
Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression. Br J Cancer (2000) 1.10
Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoids. Biochem J (2000) 1.09
OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer. Cell Death Dis (2011) 1.06
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene (2012) 1.03
Intestinal cell kinase, a MAP kinase-related kinase, regulates proliferation and G1 cell cycle progression of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2009) 1.01
The importance of ERK activity in the regulation of cyclin D1 levels and DNA synthesis in human cultured airway smooth muscle. Br J Pharmacol (2000) 1.00
Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry. PLoS One (2010) 0.99
c-Myc cooperates with activated Ras to induce the cdc2 promoter. Mol Cell Biol (1994) 0.99
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst (2013) 0.98
Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway. Cell Cycle (2009) 0.92
New frontiers in translational control of the cancer genome. Nat Rev Cancer (2016) 0.92
Divergent functions for eIF4E and S6 kinase by sonic hedgehog mitogenic signaling in the developing cerebellum. Oncogene (2011) 0.86
Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma. Proc Natl Acad Sci U S A (2014) 0.84
Data mining for gene networks relevant to poor prognosis in lung cancer via backward-chaining rule induction. Cancer Inform (2007) 0.84
The translation factor eIF6 is a Notch-dependent regulator of cell migration and invasion. PLoS One (2012) 0.84
Reduced eukaryotic initiation factor 2Bepsilon-subunit expression suppresses the transformed phenotype of cells overexpressing the protein. Cancer Res (2008) 0.82
Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entry. Mol Syst Biol (2012) 0.82
PKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells. Leuk Res Treatment (2012) 0.82
Novel regulatory factors interacting with the promoter of the gene encoding the mRNA cap binding protein (eIF4E) and their function in growth regulation. Mol Cell Biol (1998) 0.81
Regulation of PERK-eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes. Nat Commun (2016) 0.80
Determining PTEN functional status by network component deduced transcription factor activities. PLoS One (2012) 0.79
Endometrial cancer. Obstet Gynecol Clin North Am (2012) 0.79
Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells. Oncotarget (2016) 0.77
Targeting MYC in cancer therapy: RNA processing offers new opportunities. Bioessays (2016) 0.77
p63α modulates c-Myc activity via direct interaction and regulation of MM1 protein stability. Oncotarget (2016) 0.75
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell (1983) 17.87
An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol (1991) 12.00
G1 events and regulation of cell proliferation. Science (1989) 9.73
Sequence-specific DNA binding by the c-Myc protein. Science (1990) 7.75
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature (1990) 7.74
Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci U S A (1987) 7.38
Translocations among antibody genes in human cancer. Science (1983) 6.20
myc function and regulation. Annu Rev Biochem (1992) 5.33
Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science (1985) 5.08
The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J (1991) 4.96
Animal cell cycle. Annu Rev Biochem (1978) 4.80
Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (1989) 4.65
Growth factor-induced delayed early response genes. Mol Cell Biol (1992) 3.03
DNA sequences that mediate attenuation of transcription from the mouse protooncogene myc. Proc Natl Acad Sci U S A (1989) 1.94
Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Mol Cell Biol (1989) 1.84
Phosphorylation of eukaryotic translation initiation factor 4E is increased in Src-transformed cell lines. Mol Cell Biol (1991) 1.78
Are myc proteins transcription factors? Cancer Cells (1990) 1.21
c-myc oncoprotein function. Biochim Biophys Acta (1991) 1.12
Increased eIF-2 alpha expression in mitogen-activated primary T lymphocytes. EMBO J (1990) 1.11
Regulation of translation initiation factor gene expression during human T cell activation. J Biol Chem (1992) 1.08
Ras transformation of cloned rat embryo fibroblasts results in increased rates of protein synthesis and phosphorylation of eukaryotic initiation factor 4E. J Biol Chem (1992) 1.08
Retropseudogenes constitute the major part of the human elongation factor 1 alpha gene family. Nucleic Acids Res (1990) 1.02
Isolation and characterization of the promoter and flanking regions of the gene encoding the human protein-synthesis-initiation factor 2 alpha. Gene (1989) 0.97
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (1994) 5.34
Osmotic control of kdp operon expression in Escherichia coli. Proc Natl Acad Sci U S A (1981) 5.27
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol (1979) 4.86
Glucose transport in isolated brush border membrane from rat small intestine. J Biol Chem (1973) 4.75
Cation transport in Escherichia coli. VIII. Potassium transport mutants. J Gen Physiol (1976) 4.51
Salmonellosis associated with marijuana: a multistate outbreak traced by plasmid fingerprinting. N Engl J Med (1982) 4.03
Rat intestinal microvillus membranes. Purification and biochemical characterization. Biochem J (1968) 3.66
Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet (1997) 3.66
Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders. Gastroenterology (1974) 3.33
Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast. Genes Dev (1997) 3.31
The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med (1971) 3.31
Energy coupling to net K+ transport in Escherichia coli K-12. J Biol Chem (1977) 3.18
IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell (2001) 3.10
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med (1996) 3.04
Intestinal uptake of macromolecules: effect of oral immunization. Science (1972) 2.80
Vanadate inhibition of sarcoplasmic reticulum Ca2+-ATPase and other ATPases. Biochem Biophys Res Commun (1979) 2.77
Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol (1993) 2.75
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 2.59
Small intestinal permeability to macromolecules. Transmission of horseradish peroxidase into mesenteric lymph and portal blood. Lab Invest (1971) 2.46
Biogenesis of intestinal plasma membrane: posttranslational route and cleavage of sucrase-isomaltase. Proc Natl Acad Sci U S A (1979) 2.45
Increased uptake of amino acids and 2-deoxy-D-glucose by virus-transformed cells in culture. Proc Natl Acad Sci U S A (1972) 2.41
Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med (1978) 2.30
An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol Cell Biol (1996) 2.22
Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science (1985) 2.22
Small intestinal absorption of horseradish peroxidase. A cytochemical study. Lab Invest (1971) 2.20
The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. J Clin Invest (1975) 2.13
Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels. J Biol Chem (1995) 2.09
Molecular physiology of sodium-glucose cotransporters. Physiol Rev (1994) 2.06
Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis. Gastroenterology (1984) 2.06
Composition of human colonic mucin. Selective alteration in inflammatory bowel disease. J Clin Invest (1983) 2.03
Isovaleric acidemia: a new genetic defect of leucine metabolism. Proc Natl Acad Sci U S A (1966) 2.00
Identification of the structural proteins of an ATP-driven potassium transport system in Escherichia coli. Proc Natl Acad Sci U S A (1978) 1.98
Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med (1997) 1.97
Coordination of cell growth with cell division. Curr Opin Genet Dev (1999) 1.87
Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination. Ophthalmology (2000) 1.86
Functional organization of the kdp genes of Escherichia coli K-12. J Bacteriol (1978) 1.84
Intestinal antibodies. N Engl J Med (1977) 1.82
Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol (1978) 1.75
Cation transport in Escherichia coli. IX. Regulation of K transport. J Gen Physiol (1978) 1.74
Energy-requiring translocation of the OmpA protein and alkaline phosphatase of Escherichia coli into inner membrane vesicles. J Bacteriol (1984) 1.74
Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad Sci U S A (1990) 1.72
Very low density lipoproteins in intestinal lymph: origin, composition, and role in lipid transport in the fasting state. J Clin Invest (1969) 1.71
Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci U S A (1997) 1.68
Normal serum ferritin concentrations in precirrhotic hemochromatosis. N Engl J Med (1976) 1.68
A physician-based voluntary reporting system for adverse events and medical errors. J Gen Intern Med (2001) 1.68
Circulating antibodies to bovine albumin in ulcerative colitis and Crohn's disease. Characterization of the antibody response. Gastroenterology (1976) 1.67
Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis. Proc Natl Acad Sci U S A (1989) 1.67
Macromolecular absorption. Mechanism of horseradish peroxidase uptake and transport in adult and neonatal rat intestine. J Cell Biol (1972) 1.66
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci U S A (1991) 1.65
Hepatitis-associated antigen and hepatoma in the U.S. Lancet (1971) 1.64
Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest (1975) 1.63
GALACTOSEMIA, A CONGENITAL DEFECT IN A NUCLEOTIDE TRANSFERASE: A PRELIMINARY REPORT. Proc Natl Acad Sci U S A (1956) 1.60
Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver. N Engl J Med (1971) 1.59
Discrimination between Rb+ and K+ by Escherichia coli. Biochim Biophys Acta (1977) 1.57
Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A (1978) 1.57
Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest (1993) 1.55
Protein uptake by the intestine: evidence for absorption of intact macromolecules. Gastroenterology (1974) 1.53
Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev (2001) 1.53
Intestinal uptake of macromolecules. II. Effect of parenteral immunization. J Immunol (1973) 1.53
Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis. Proc Natl Acad Sci U S A (1975) 1.49
Preparation and characterization of the lateral and basal plasma membranes of the rat intestinal epithelial cell. Biochem J (1972) 1.49
Intestinal uptake of macromolecules. III. Studies on the mechanism by which immunization interferes with antigen uptake. J Immunol (1975) 1.49
Fibronectin synthesis by epithelial crypt cells of rat small intestine. Proc Natl Acad Sci U S A (1978) 1.49
Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc Natl Acad Sci U S A (1981) 1.48
Relative contributions of afferent vagal fibers to resistance to diet-induced obesity. Dig Dis Sci (2011) 1.48
Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci U S A (1992) 1.48
Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet (1970) 1.46
Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc Natl Acad Sci U S A (1994) 1.45
Absorption of medium and long chain triglycerides: factors influencing their hydrolysis and transport. J Clin Invest (1966) 1.44
Monoclonal antibodies to sucrase/isomaltase: probes for the study of postnatal development and biogenesis of the intestinal microvillus membrane. Proc Natl Acad Sci U S A (1980) 1.44
Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro (1984) 1.43
The turnover of disaccharidases and brush border proteins in rat intestine. Biochim Biophys Acta (1971) 1.43
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42
Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc Natl Acad Sci U S A (1998) 1.41
Lipid composition of the isolated rat intestinal microvillus membrane. Biochem J (1968) 1.40
Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins. N Engl J Med (1976) 1.39
Drug therapy: Cimetidine. N Engl J Med (1978) 1.38
Rapid identification of low level hepatitis B-related viral genome in serum. J Clin Invest (1989) 1.37
Serum lysozyme in Crohn's disease and ulcerative colitis. N Engl J Med (1975) 1.36
Isovaleric acidemia. Clinical features of a new genetic defect of leucine metabolism. N Engl J Med (1967) 1.33
Effect of fasting versus feeding on the rat small intestine. Morphological, biochemical, and functional differences. Gastroenterology (1970) 1.32
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci U S A (1996) 1.31
Study of intestinal cell differentiation with monoclonal antibodies to intestinal cell surface components. Dev Biol (1985) 1.29
Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1994) 1.28
Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology (1994) 1.28
msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation. Proc Natl Acad Sci U S A (1996) 1.27
Human -fetoprotein. Isolation, characterization, and demonstration of microheterogeneity. J Biol Chem (1972) 1.26
Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology (1979) 1.24
Ranitidine: a new H2-receptor antagonist. N Engl J Med (1983) 1.24
The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors. J Biol Chem (2000) 1.23
Human isoferritins: organ specific iron and apoferritin distribution. Br J Haematol (1975) 1.23
Biochemical aspects of fat absorption. Gastroenterology (1966) 1.23
Monoclonal radioimmunoassays for hepatitis B surface antigen: demonstration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immune complexes. Proc Natl Acad Sci U S A (1982) 1.23
Demonstration of previously undetected hepatitis B viral determinants in an Australian Aboriginal population by monoclonal anti-hbs antibody radioimmunoassays. Lancet (1982) 1.23
The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene. Proc Natl Acad Sci U S A (1992) 1.22
Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc Natl Acad Sci U S A (1995) 1.22
Diurnal rhythmicity in intestinal SGLT-1 function, V(max), and mRNA expression topography. Am J Physiol Gastrointest Liver Physiol (2001) 1.22
Monoclonal IgM radioimmunoassay for hepatitis B surface antigen: high binding activity in serum that is unreactive with conventional antibodies. Proc Natl Acad Sci U S A (1982) 1.22